Full Text View
Tabular View
No Study Results Posted
Related Studies
Carvedilol Versus Verapamil in Chronic Heart Failure Secondary to Non-Ischemic Cardiomyopathy
This study is currently recruiting participants.
Study NCT00348530   Information provided by Medical University of Silesia
First Received: July 3, 2006   Last Updated: October 17, 2006   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Systolic Heart Failure
Myocardial Disease
Cardiomyopathy
Additional conditions recognized in this trial
Cardiomyopathies
Heart Failure
Heart Failure, Systolic
More general conditions related to this trial
Cardiovascular Diseases
Heart Diseases
Interventions listed in this trial
Verapamil
Additional drug interventions recognized in this trial
Carvedilol
Diltiazem
More general drug interventions related to this trial
Adrenergic Agents
Adrenergic alpha-Antagonists
Adrenergic Antagonists
Adrenergic beta-Antagonists
Anti-Arrhythmia Agents
Antihypertensive Agents
Calcium Channel Blockers
Cardiovascular Agents
Membrane Transport Modulators
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Vasodilator Agents
Sponsors listed in this trial
Medical University of Silesia


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services